Novo Nordisk A/S (NVO) stock slides, “Hold” rating reiterated by Credit Suisse Group AG Analysts

Novo Nordisk A/S (NYSE: NVO) shares fell on Thursday Dec 1 with lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, U.S. stocks opened with slight gains on Thursday.

The Dow Jones Industrial Average DJIA, +0.31% rose 38.22 points, or 0.2%, to 19,174, while the S&P 500 SPX, +0.01% added 2.1 points to 2,202, a rise of 0.1%.

The Nasdaq Composite Index COMP, -0.32% rose less than 1 point to 5,323, essentially unchanged on the day.
Novo Nordisk A/S (NYSE: NVO) had its Hold rating reiterated by equities researchers at Credit Suisse Group AG in a research note to investors. With a rating of Hold on the stock, the company has a 52-week high of $59.00. The one-year price target of $35.10 is higher than the opening price of $33.69, that has caused a fair amount of other analysts to comment on the company in recent days. Stock prices sometimes get a bounce to the upside when analysts reiterate coverage.

Shares of Novo Nordisk A/S (NYSE: NVO) opened at $33.69 on Tuesday and has traded in a range between, $33.54 and $33.74, and last traded at $33.56, which represents a dip of $0.04 per share or -0.12% compared to the previous closing price.

Novo Nordisk A/S (NYSE: NVO) now has a market cap of 84.79B.

Novo Nordisk A/S (NYSE: NVO) Average Daily Trading Volume

The stock’s average daily volume is 4,170,290 shares out of a total float 1,819,686,000 and some 898,920 shares crossed the trading desk yesterday, below the average. Momentum traders often use swings in trading volume to identify large volume aggregation or distribution by institutional investors, so trading volume is likely to increase in the next few days.

However, a single day of heavy buy side trading is not enough to determine a trend. So market traders will continue to look for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship commonly refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors have teams of analysts that investigate thousands of stocks, so it is good validation to see them buying a stock you are considering.

Novo Nordisk A/S (NYSE: NVO) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

Traders are able to make make more impactful choices on trades when they follow the trading habits of professional investors.

With that in mind, Novo Nordisk A/S (NYSE: NVO) now has a 50-day MA of $36.33 and 200-day MA of $47.04. It has traded in a 52-week range between $30.89 – 59.000 and today’s last price is 43.12%% lower than the 52 week high of $59.00.

Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors seek companies that have increased their earnings at least 25% or more over 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *